Page last updated: 2024-08-26

peptide elongation factor 2 and Leukemia, Myeloid

peptide elongation factor 2 has been researched along with Leukemia, Myeloid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, X; Zuckerman, KS1

Reviews

1 review(s) available for peptide elongation factor 2 and Leukemia, Myeloid

ArticleYear
Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
    Leukemia & lymphoma, 2000, Volume: 38, Issue:3-4

    Topics: CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Gene Expression Regulation, Leukemic; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Macromolecular Substances; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplastic Stem Cells; Nuclear Proteins; Peptide Elongation Factor 2; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proteins; Retinoblastoma Protein; Retinoblastoma-Like Protein p107; Retinoblastoma-Like Protein p130; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Suppressor Proteins

2000